For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
Scope of the Report:
The global average price of Self-Injection Device is in the increasing trend, from 14.4 USD/Unit in 2012 to 15.2 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
Self-Injection Device is widely used for insulin injection, epinephrine injection and other field. The most proportion of Self Injection Device is used for insulin injection, and the proportion in 2016 is 86.5%. The trend of self-injection devices used for insulin injection is decreasing.
Europe is the largest consumption place, with a consumption market share nearly 42% in 2016. Following Europe, North America is the second largest consumption place with the consumption market share of 31%.
The worldwide market for Self Injection Device is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 9950 million US$ in 2024, from 7090 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Self Injection Device in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Novo Nordisk
- Mylan
- Pfizer
- Sanofi
- BD
- Eli Lilly
- Gerresheimer
- Dongbao
- Ypsomed
- Owen Mumford
- Antares Pharma
- Haselmeier
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Reusable Self Injection Device
- Disposable Self Injection Device
Market Segment by Applications, can be divided into
- Insulin Injection
- Epinephrine Injection
- Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Self Injection Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Self Injection Device, with price, sales, revenue and global market share of Self Injection Device in 2017 and 2018.
Chapter 3, the Self Injection Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Self Injection Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Self Injection Device market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Self Injection Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.